Customers looking for an mRNA therapeutic partner should prioritize operational excellence and choose flexible CDMOs.

Home > Pressemitteilung: New solutions for the RNA medicine of ... At the RNApp graduate school, young researchers are working to make RNA-based drugs safer and more effective.

Phospholipids are key components of cell membranes, and are used in the creation of lipid nanoparticles (LNPs) for targeted drug delivery. DOPE-Cx can form a special structure called a “cubic phase,” ...

At present, over 45 industry players are engaged in the development of mRNA drug candidates for a wide range of disease indications. The success of COVID-19 vaccines, growing research activity and ...

Five researchers have been jointly awarded one of this year's Breakthrough Prizes in Life Sciences for their contributions to ...

The global lipid nanoparticles market, valued at US$ 820.51 million in 2023, is projected to experience significant growth, with an expected market valuation of US$ 2,387.98 million by 2032. This ...

The bill aims to close loopholes exploited by drug traffickers who smuggle substances with chemical compositions similar to fentanyl but are different enough to evade legal penalties. "What this ...

Presently, over 235 mRNA drug candidates are available in the market or under development; majority of these drug candidates are vaccines using lipid nanoparticles as delivery systems. Several ...

A single dose of an experimental drug dramatically reduced levels of a deadly form of cholesterol, often thought to be ...